Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1951 2
1952 2
1953 4
1954 1
1955 2
1956 2
1957 4
1958 2
1960 3
1961 2
1962 2
1963 3
1964 6
1966 1
1967 1
1969 1
1974 1
1979 2
1980 1
1982 1
1984 3
1985 1
1986 2
1988 1
1989 1
1990 7
1991 9
1992 6
1993 8
1994 5
1995 5
1996 8
1997 6
1998 18
1999 20
2000 23
2001 21
2002 26
2003 37
2004 34
2005 60
2006 61
2007 84
2008 87
2009 85
2010 91
2011 105
2012 101
2013 118
2014 153
2015 172
2016 196
2017 208
2018 205
2019 204
2020 250
2021 227
2022 193
2023 234
2024 210
2025 243
2026 112

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,205 results

Results by year

Filters applied: . Clear all
Page 1
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial.
Tombal B, Choudhury A, Saad F, Gallardo E, Soares A, Loriot Y, McDermott R, Rodriguez-Vida A, Isaacsson Velho P, Nolè F, Cruz F, Roumeguere T, Daugaard G, Yamamura R, Bompas E, Maroto P, Gomez Veiga F, Skoneczna I, Martins da Trindade K, Mavignier Carcano F, Lecouvet F, Coens C, Poncet C, Fournier B, Gillessen S. Tombal B, et al. Among authors: soares a. Ann Oncol. 2025 Sep;36(9):1058-1067. doi: 10.1016/j.annonc.2025.05.011. Epub 2025 May 30. Ann Oncol. 2025. PMID: 40450503 Free article. Clinical Trial.
Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024.
Rodrigues C, Bouchez V, Soares A, Trombert-Paolantoni S, Aït El Belghiti F, Cohen JF, Armatys N, Landier A, Blanchot T, Hervo M; REMICOQ study group; Toubiana J, Brisse S. Rodrigues C, et al. Among authors: soares a. Euro Surveill. 2024 Aug;29(31):2400459. doi: 10.2807/1560-7917.ES.2024.29.31.2400459. Euro Surveill. 2024. PMID: 39092529 Free PMC article.
Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study.
Santoni M, Büttner T, Rescigno P, Fiala O, Cavasin N, Basso U, Taha T, Massari F, Myint ZW, Formisano L, Galli L, Scagliarini S, Matrana MR, Facchini G, Bamias A, Messina C, Zacchi F, Manneh RK, Roviello G, Santini D, Poprach A, Navratil J, Uher M, Calabrò F, Pierce E, Berardi R, Aurilio G, Zakopoulou R, Rizzo A, Ansari J, Rizzo M, Bisonni R, Mollica V, Incorvaia L, Spinelli G, Jiang XY, Chandler RA, Grillone F, Morelli F, Buti S, Maluf FC, Marques Monteiro FS, Battelli N, Porta C, Caffo O, Soares A. Santoni M, et al. Among authors: soares a. Eur Urol Oncol. 2025 Apr;8(2):444-451. doi: 10.1016/j.euo.2024.11.005. Epub 2024 Nov 29. Eur Urol Oncol. 2025. PMID: 39613567 Free article.
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial.
Agarwal N, Azad AA, Carles J, Matsubara N, Oudard S, Saad F, Merseburger AS, Soares A, McGregor BA, Zurawski B, Tsiatas M, North S, Bondarenko I, Alfie M, Bournakis E, Antonuzzo L, Evilevitch L, Simmons A, Wang F, Ferraldeschi R, Nandoskar P, Pal SK. Agarwal N, et al. Among authors: soares a. Lancet Oncol. 2025 Jul;26(7):860-876. doi: 10.1016/S1470-2045(25)00209-8. Epub 2025 Jun 13. Lancet Oncol. 2025. PMID: 40523369 Clinical Trial.
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study.
Porta C, Massari F, Taha T, Grande E, Bourlon MT, Kanesvaran R, Basso U, Molina-Cerrillo J, Alonso-Gordoa T, Myint ZW, Fornarini G, Buttner T, Park SH, Ürün Y, De Giorgi U, Pichler R, Rescigno P, Buchler T, Studentova H, Melichar B, Ansari J, Mollica V, Kucharz J, Rizzo M, Rizzo A, Kopp RM, Buti S, Monteiro FSM, Soares A, Bamias A, Santoni M. Porta C, et al. Among authors: soares a. Cancer Immunol Immunother. 2025 May 9;74(7):196. doi: 10.1007/s00262-025-04019-x. Cancer Immunol Immunother. 2025. PMID: 40343572 Free PMC article.
Pigmented contact cheilitis: a systematic review.
Figueiredo AS, Braz GL, Garcia FF, Moreno LB, Soares AC, Calderipe CB, Vasconcelos AC. Figueiredo AS, et al. Among authors: soares ac. Med Oral Patol Oral Cir Bucal. 2024 Nov 1;29(6):e727-e733. doi: 10.4317/medoral.26484. Med Oral Patol Oral Cir Bucal. 2024. PMID: 39396149 Free PMC article.
177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study.
Mandel P, Groener D, Follacchio G, Ürün Y, Bourlon MT, Sabet A, Grünwald F, Tural D, Büttner T, Kopp RM, Taha T, Chun FK, Facchini G, Myint ZW, Seront E, Conteduca V, Quiroga MNG, Aurilio G, Palacios GA, Bögemann M, Roviello G, Matrana MR, Sammarco E, Laguado MIZ, Galli L, Ansari J, Danielli L, Molina-Cerrillo J, Rescigno P, Yazgan SC, Bastos DA, Jazieh AR, Monteiro FSM, Soares A, Massari F, Wenzel M, Capoccetti F, Santoni M. Mandel P, et al. Among authors: soares a. Eur J Cancer. 2025 Oct 16;229:115789. doi: 10.1016/j.ejca.2025.115789. Epub 2025 Sep 12. Eur J Cancer. 2025. PMID: 40987027 Free article.
A roadmap for equitable reuse of public microbiome data.
Hug LA, Hatzenpichler R, Moraru C, Soares AR, Meyer F, Heyder A; Data Reuse Consortium; Probst AJ. Hug LA, et al. Among authors: soares ar. Nat Microbiol. 2025 Oct;10(10):2384-2395. doi: 10.1038/s41564-025-02116-2. Epub 2025 Sep 26. Nat Microbiol. 2025. PMID: 41006832 Review.
3,205 results